In the Press

The human microbiome contains a community of microorganisms that include viruses. This is called the human virome, a community of both beneficial and pathogenic viruses.

The World Health Organization (WHO) today strongly recommended Pfizer's Paxlovid drug for mild to moderately sick COVID-19 patients who are part of high-risk groups, but also called for efforts to boost access to the treatment for low- to middle-income countries.

Two studies published yesterday in The Lancet Public Health detail how COVID-19 restrictions moderately affected adults' mental health in 15 nations, with one finding that the type of lockdowns were linked to the level of distress and opinion of the government, and the other suggesting that mental health declined slightly but significantly under lockdown—especially among women.

Air pollution can affect human health, having both short-term (e.g., irritation to the eyes, headaches and coughing) and long-term (e.g., chronic respiratory disease and heart disease) effects [1].

From August 2021 to date, Paraná has recorded more than 80,000 notifications of dengue and five deaths from the disease. With the increase in cases, the Secretary of State for Health declared a situation of epidemic of the disease from this Tuesday.

Tirzepatide is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist under development for the treatment of type 2 diabetes. In this study, we used continuous glucose monitoring (CGM) to compare the 24 h glucose profile for participants given tirzepatide compared with those given insulin degludec.

COVID-19 was the third leading cause of death in the United States last year, and deaths from COVID-19 increased by 1% in 2021 over 2020, according to new data from the National Vital Statistics System released today by the Centers for Disease Control and Prevention (CDC).

Associations between vitamin D (VD) deficiency and the risk of SARS-CoV-2 infection have been documented in cross-sectional population studies. Intervention studies in patients with moderate to severe COVID-19 have failed to consistently document a beneficial effect.

More awareness and more detailed health records may explain rise; end-of-life care shifting as diagnoses allow for more advance planning.

Researchers at the Universities of Bonn and Sao Paulo have succeeded in mitigating chronic inflammation in mice using customized "mini-antibodies." These nanobodies enabled them to dissolve molecular complexes in tissue that normally activate the immune system.